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background:  Troponin elevation frequently provokes reflexive referral to invasive coronary angiography (ICA). Despite the utilization of 
this biomarker, 30-60% of coronary angiograms show no obstructive coronary artery disease (CAD). We assessed the optimal troponin-I 
threshold to predict obstructive CAD and the interaction of comorbidities with this relationship in patients referred for index ICA.
methods:  A retrospective analysis was performed on 935 consecutive patients undergoing index ICA for ischemia evaluation. ROC 
analysis determined the optimal troponin-I threshold for identifying 70% coronary stenosis. Interactions with troponin were assessed using 
logistic regression analysis.
Results:  Of the 935 patients studied, 55.6% were male with a median age of 62 years and a median 10-year ASCVD risk score of 17.7%. 
Of the 351 without CAD, 110 (38.5%) had a positive troponin. ROC analysis identified an optimal troponin threshold of 0.15, with an AUC 
of 0.64, p<0.0001. The PPV and NPV were 75.8% and 51.4% respectively. Of those with troponin ≥0.15, 70 of 239 (29.3%) had no CAD. 
There were no significant interactions between troponin and congestive heart failure (CHF), chronic kidney disease (CKD), symptoms, 
diabetes, or ASCVD risk. Patients without CAD and with troponin ≥0.15 were 61.5% male; 50.0% experienced angina, 72.6% had elevated 
ASCVD risk scores, 36.9% had diabetes, 49.2% had CHF, and 6.2% had CKD. Patients without CAD were more likely to be asymptomatic 
(p=0.004) and lack hyperlipidemia (p=0.003). In asymptomatic patients with troponin ≥0.15, 80% had no evidence of CAD.
conclusion:  In this analysis, a substantial percentage of patients with an elevated serum troponin had no obstructive CAD on ICA. 
Asymptomatic patients with positive troponin had an especially low likelihood of disease. Microvascular disease is a potential etiology. Our 
findings suggest troponin elevation should not obligate ICA. Additional variables should be considered. However, variables commonly felt to 
alter the predictive value of troponin, such as CHF and CKD, did not interact significantly. Further research is needed to evaluate the role of 
troponin in referral to ICA and fully define its clinical utility.
